Skip to content
Homepage
Author:
Waters Corporation
Posted Date:
July 27, 2026
Waters Launches Industry’s Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer
Waters Corporation
July 27, 2026
Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call
Waters Corporation
July 2, 2026
IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine
Waters Corporation
June 24, 2026
Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis
Waters Corporation
June 9, 2026
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis
Waters Corporation
June 8, 2026
Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics
Waters Corporation
June 3, 2026
Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics
Waters Corporation
June 1, 2026
Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research
Waters Corporation
June 1, 2026
Waters Corporation to Present at the Jefferies Global Healthcare Conference
Waters Corporation
May 18, 2026
Waters Corporation Schedules First Quarter 2026 Earnings Conference Call
Waters Corporation
April 20, 2026
1
2
Next
